Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Time is the primary evidence-backed intervention. Acute cannabis toxicity follows a self-limiting course, and the clinical ...

Brianna Tobritzhofer is a nationally credentialed Registered Dietitian and experienced health writer with over a decade of leadership in nutrition program development, policy compliance, and public ...

Special Operations Forces are elite, highly trained military units designed for clandestine, high-risk missions often behind ...

Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. Many people still don’t fully understand the nature of Parkinson’s disease, and far less may be able ...

Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development.

Month Club? The biotech company just disclosed a potential $5 billion buyout of a German cancer drug company ...

Every day, approximately 586 people in the United States are hospitalized for a traumatic brain injury (TBI), and millions live with disability as a result of a brain injury. 1,2 In March, clinicians ...

Explore how Neuralink brain chips and ongoing Neuralink trials are advancing brain-computer interface technology, enabling thought control, digital communication, and groundbreaking medical ...